glp-1 constipation law firm in louisiana lawmakers are considering a bill that would expand Medicaid access to drugs for obesity treatment, a move supporters say could improve health outcomes and reduce long-term costs. https://bit.ly/4usEGVI GLP-1 RA Lawsuit - Shreveport

Differential sensitivity of inflammatory macrophages and alternatively activated macrophages to ferroptosis

Data was self-reported by 229 surveyed customers on their third check-in of use between 4/7/22 & 8/30/23 by AgelessRx customers who were approved for a prescription after completing an assessment with a medical provider

The New England Journal of Medicine commentary accompanying SURPASS-2 stated: "The dual incretin approach appears to exploit receptor crosstalk in ways that amplify downstream insulin secretion beyond what GLP-1 receptor agonism alone can achieve at comparable tolerability." [30] SURPASS-1: Monotherapy Benchmark SURPASS-1 (N=478) established monotherapy efficacy, with tirzepatide 15 mg reducing A1C by 2.07 percentage points and body weight by 9.5 kg at 40 weeks versus placebo [31]

Some providers recommend continuing dietary support, accountability check-ins, or even lower-dose therapy temporarily if you experience significant weight rebound during the three-month washout period